Pilot Study of Continuous Glucose Monitoring for Postpartum Glucose Screening

Enrolling by invitation · Not applicable

Conditions studied: Gestational Diabetes

In brief

The oral glucose tolerance test (OGTT) is the standard of care in the postpartum period to screen patients with gestational diabetes mellitus (GDM) for persistent dysglycemia. However, most patients find it burdensome and dread having to do it. Adherence rates are low (18-61%), impeding initiation of follow-up care to improve diabetes-related outcomes in subsequent pregnancies and long-term.

Key facts

Study ID

NCT07332416

Run by

Wake Forest University Health Sciences

People needed

1300

Starts

2026-07-06

Expected to finish

2027-01-01

Last updated by the study team

2026-07-10

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• 12-16 weeks postpartum
• Gestational diabetes Mellitus (GDM) diagnosis in most recent pregnancy
• Oral Glucose Tolerance Test (OGTT) order placed in the medical record

You may not qualify if…

• Pre-gestational diabetes
• Non-English language

Where it is running

• Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.